Process for preparing macrocyclic dipeptides which are suitable for the treatment of hepatitis C viral infections

Details for Australian Patent Application No. 2005224092 (hide)

Owner Boehringer Ingelheim International, GmbH

Inventors Xu, Yibo; Gallou, Fabrice; Busacca, Carl Alan; Haddad, Nizar; Wang, XiaoJun; Zhang, Li; Yee, Nathan K.; Wei, Xudong; Farina, Vittorio; Xu, Jinghua

Agent Davies Collison Cave

Pub. Number AU-A-2005224092

PCT Pub. Number WO2005/090383

Priority 60/578,123 08.06.04 US; 60/553,317 15.03.04 US

Filing date 11 March 2005

Wipo publication date 29 September 2005

International Classifications

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/090383 Priority application(s): WO2005/090383

7 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005224096-Rheologically unique intaglio printing inks

2005224091-Novel compounds as opioid receptor modulators